Diabetes & Endocrinologycongenital adrenal hyperplasia21-hydroxylase deficiency
Survival Without Glucocorticoid Treatment in Classic and Non-Classic 21-Hydroxylase Deficiency: A Retrospective Cohort Study
By MedXY|Jul 28, 2026
A multicenter retrospective study found that 48% of patients with classic 21-hydroxylase deficiency never received glucocorticoid treatment, and 71% experienced no adrenal crises during untreated periods, including illness or surgery.
